Bruno Strigini

Bruno Strigini is an accomplished executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as Chairman at Arvic-bio and Director at multiple organizations including Neopharmed Gentili S.P.A., Kedrion Biopharma, Neuraxpharm, Owkin, OneHealth Partners, and Kos, Bruno Strigini also holds the position of Senior Advisor at Permira. Previous leadership roles include Chief Executive Officer at Novartis Oncology and President for Europe and Canada at MSD. Bruno Strigini's educational background includes an MBA from IMD, a PharmD from the University of Montpellier, and an MSc in Microbiology from Heriot-Watt University.